India orders top drugmaker to halt eye medicine production at plant over quality lapses
India orders top drugmaker to halt eye medicine production at plant over quality lapses CNA Sun Pharma terms recalled eye drugs production halt a ‘voluntary call’ pharma.economictimes.indiatimes.com Ophthalmic products recalled: Why drug regulators ordered Sun Pharma to halt eye-drop production at Assam plant? Livemint Sun Pharma taking remedial action, following voluntary withdrawal of 11 eye drops:...
Key Takeaways
- India orders top drugmaker to halt eye medicine production at plant over quality lapses CNA Sun Pharma terms recalled eye drugs production halt a ‘voluntary call’ pharma.economictimes.indiatimes.com Ophthalmic products recalled: Why drug regulators ordered Sun Pharma to halt eye-drop production at Assam plant?
- Livemint Sun Pharma taking remedial action, following voluntary withdrawal of 11 eye drops: Management BusinessLine India orders Sun Pharma to halt eye-care drug production at plant after quality lapses TradingView
- Full details and original dispatch available below.
India orders top drugmaker to halt eye medicine production at plant over quality lapses CNA Sun Pharma terms recalled eye drugs production halt a ‘voluntary call’ pharma.economictimes.indiatimes.com Ophthalmic products recalled: Why drug regulators ordered Sun Pharma to halt eye-drop production at Assam plant? Livemint Sun Pharma taking remedial action, following voluntary withdrawal of 11 eye drops: Management BusinessLine India orders Sun Pharma to halt eye-care drug production at plant after quality lapses TradingView
Original Publisher Attribution
This summary was curated from CNA.